Search Results - "Lopez, Laura Jolis"

Abstract CT212: A phase III randomized study of paclitaxel (T) and trastuzumab (H) versus T, H and lapatinib (L) in first line treatment of HER2+ metastatic breast cancer (MBC) by Crown, John, Jacot, William, Collins, Denis M., Coate, Linda, Saetersdal, Anna, Kennedy, M John, Kelly, Catherine, De Ibarguen, Blanca Cantos Sanchez, Conejero, Raquel Andrés, Costa, Luis, Brito, Margarida, Keane, Maccon, Rovira, Pedro Sanchez, Martin, Miguel, O'Connor, Miriam, Vazquez, Manuel Ramos, Alvarez, Elena, O'Reilly, Seamus, Mattson, Johanna, Lopez, Laura Jolis, Lescure, Alvaro Rodriguez, Blanco, Esperanza, Muino, Coralia Bueno, Moulton, Brian, O'Donovan, Norma, Hernando, Andres, Nolan, Marc, Parker, Imelda, Gullo, Giuseppe, Hennessy, Bryan

“…Background: The addition of H to chemotherapy improved disease outcome in HER2+ MBC. The combination of H and L with chemotherapy improved event free survival…”
Get full text

Individualization of treatment strategies by Fernández Ortega, Adela, Jolis López, Laura, Viñas Villaró, Gemma, Villanueva Vázquez, Rafael, García Arias, Alicia, González Farré, Xavier, González Jiménez, Sonia, Saura Manich, Cristina, Cortés Castán, Javier

“…This section focuses on different aspects of the individualization of hormone treatment in breast cancer. This includes tumor-related biological factors such…”
Get full text